Chemical Component Summary | |
---|---|
Name | dolastatin-10 |
Synonyms | N,N-dimethyl-L-valyl-N-[(3R,4S,5S)-3-methoxy-1-{(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-{[(1S)-2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino}propyl]pyrrolidin-1-yl}-5-methyl-1-oxoheptan-4-yl]-N-methyl-L-valinamide |
Identifiers | (2~{S})-2-[[(2~{S})-2-(dimethylamino)-3-methyl-butanoyl]amino]-~{N}-[(3~{R},4~{S},5~{S})-3-methoxy-1-[(2~{S})-2-[(1~{R},2~{R})-1-methoxy-2-methyl-3-oxidanylidene-3-[[(1~{S})-2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1-yl]-5-methyl-1-oxidanylidene-heptan-4-yl]-~{N},3-dimethyl-butanamide |
Formula | C42 H68 N6 O6 S |
Molecular Weight | 785.091 |
Type | NON-POLYMER |
Isomeric SMILES | CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@@H](C)C(=O)N[C@@H](Cc2ccccc2)c3nccs3)OC)OC)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)N(C)C |
InChI | InChI=1S/C42H68N6O6S/c1-13-28(6)37(47(10)42(52)35(26(2)3)45-40(51)36(27(4)5)46(8)9)33(53-11)25-34(49)48-22-17-20-32(48)38(54-12)29(7)39(50)44-31(41-43-21-23-55-41)24-30-18-15-14-16-19-30/h14-16,18-19,21,23,26-29,31-33,35-38H,13,17,20,22,24-25H2,1-12H3,(H,44,50)(H,45,51)/t28-,29+,31-,32-,33+,35-,36-,37-,38+/m0/s1 |
InChIKey | OFDNQWIFNXBECV-VFSYNPLYSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 123 |
Chiral Atom Count | 9 |
Bond Count | 125 |
Aromatic Bond Count | 11 |
Drug Info: DrugBank
DrugBank ID | DB12730 |
---|---|
Name | Dolastatin 10 |
Groups | investigational |
Description | Dolastatin 10 has been used in trials studying the treatment of Sarcoma, Leukemia, Lymphoma, Liver Cancer, and Kidney Cancer, among others. |
Synonyms | Dolastatin 10 |
Categories |
|
CAS number | 110417-88-4 |
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 9810929 |
ChEMBL | CHEMBL39541 |
ChEBI | CHEBI:67357 |